Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Information by Drug Class

Information by Drug Class

                        Prescription Stimulant Medications


                        Human Immunodeficiency Virus (HIV) Home
          Drugs
          Drug Safety and Availability
          Information by Drug Class
          All manufacturers of prescription combination drug products with more than 325 mg of acetaminophen have discontinued marketingInformation by Drug Class All manufacturers of prescription combination drug products with more than 325 mg of acetaminophen have discontinued marketing
  
  	
    Share
    Post
    Linkedin

    Email
    Print**[03-26-2014]** FDA and industry have taken action to protect consumers from the risk of severe liver damage, which can result from taking too much acetaminophen. All manufacturers of prescription combination drug products with more than 325 milligrams (mg) of acetaminophen per tablet, capsule, or other dosage unit have discontinued marketing these products.While all of these products have been discontinued and are no longer available, there are a few remaining manufacturers that have not taken the necessary administrative steps to voluntarily withdraw their applications.Today, FDA issued two Federal Register notices to formally withdraw the applications for all prescription combination drug products that contain more than 325 mg of acetaminophen per tablet, capsule, or other dosage unit. The first notice immediately withdraws FDA approval of those products for which the manufacturers asked to voluntarily withdraw their applications. The second notice addresses the applications of six manufacturers who have discontinued marketing their products but have not correctly withdrawn their applications, and announces FDA’s intention to begin a process to withdraw approval of those applications.FDA is also reminding manufacturers to update their drug listing files to reflect the withdrawal of their prescription combination drug products containing more than 325 mg of acetaminophen from the market.FDA had asked manufacturers to voluntarily withdraw these products from the market to reduce the risk of severe liver injury from inadvertent acetaminophen overdose, which can lead to liver failure, liver transplant, and death. Many consumers are unaware that multiple drug products they take (both prescription and over-the-counter) may contain acetaminophen, making it easy to accidentally take too much.

                                                                                  Content current as of:
      12/11/2014Information by Drug Class

          
                        Prescription Stimulant Medications


                        Human Immunodeficiency Virus (HIV)
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop